Cargando…
Temporal bone paragangliomas: 15 years experience()
INTRODUCTION: Temporal bone paragangliomas (TBPs) are benign tumors arising from neural crest cells located along the jugular bulbus and the tympanic plexus. In general surgical excision, radiotherapy and wait-and-scan protocols are the main management modalities for TBPs. OBJECTIVE: In this paper w...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442861/ https://www.ncbi.nlm.nih.gov/pubmed/28011121 http://dx.doi.org/10.1016/j.bjorl.2016.11.001 |
_version_ | 1784782917001543680 |
---|---|
author | Düzlü, Mehmet Tutar, Hakan Karamert, Recep Karaloğlu, Furkan Şahin, Muammer Melih Göcek, Mehmet Uğur, Mehmet Birol Göksu, Nebil |
author_facet | Düzlü, Mehmet Tutar, Hakan Karamert, Recep Karaloğlu, Furkan Şahin, Muammer Melih Göcek, Mehmet Uğur, Mehmet Birol Göksu, Nebil |
author_sort | Düzlü, Mehmet |
collection | PubMed |
description | INTRODUCTION: Temporal bone paragangliomas (TBPs) are benign tumors arising from neural crest cells located along the jugular bulbus and the tympanic plexus. In general surgical excision, radiotherapy and wait-and-scan protocols are the main management modalities for TBPs. OBJECTIVE: In this paper we aim to present our clinical experience with TBPs and to review literature data. METHODS: The patients who were operated for tympanomastoid paraganglioma (TMP) or tympanojugular paraganglioma (TJP) in our clinic in the last 15 years were enrolled in the study. A detailed patient's charts review was performed retrospectively. RESULTS: There were 18 (52.9%) cases with TMPs and 16 (47.1%) cases with TJPs, a total of 34 patients operated for TBPs in this time period. The mean age was 50.3 ± 11.7 (range 25–71 years). The most common presenting symptoms were tinnitus and hearing loss for both TMPs and TJPs. Gross total tumor resection was achieved in 17 (94.4%) and 10 (62.5%) cases for TMPs and TJPs, respectively. Five patients (31.2%) with TJP experienced facial palsy following the operation. For all the patients the mean follow-up period was 25.8 months (range 4–108 months). CONCLUSION: In conclusion, based on our findings and literature review, total surgical excision alone or with preoperative embolization is the main treatment modality for TBPs. However radiotherapy, observation protocol and subtotal resection must be considered in cases of preoperative functioning cranial nerves, large tumors and advanced age. |
format | Online Article Text |
id | pubmed-9442861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94428612022-09-09 Temporal bone paragangliomas: 15 years experience() Düzlü, Mehmet Tutar, Hakan Karamert, Recep Karaloğlu, Furkan Şahin, Muammer Melih Göcek, Mehmet Uğur, Mehmet Birol Göksu, Nebil Braz J Otorhinolaryngol Original Article INTRODUCTION: Temporal bone paragangliomas (TBPs) are benign tumors arising from neural crest cells located along the jugular bulbus and the tympanic plexus. In general surgical excision, radiotherapy and wait-and-scan protocols are the main management modalities for TBPs. OBJECTIVE: In this paper we aim to present our clinical experience with TBPs and to review literature data. METHODS: The patients who were operated for tympanomastoid paraganglioma (TMP) or tympanojugular paraganglioma (TJP) in our clinic in the last 15 years were enrolled in the study. A detailed patient's charts review was performed retrospectively. RESULTS: There were 18 (52.9%) cases with TMPs and 16 (47.1%) cases with TJPs, a total of 34 patients operated for TBPs in this time period. The mean age was 50.3 ± 11.7 (range 25–71 years). The most common presenting symptoms were tinnitus and hearing loss for both TMPs and TJPs. Gross total tumor resection was achieved in 17 (94.4%) and 10 (62.5%) cases for TMPs and TJPs, respectively. Five patients (31.2%) with TJP experienced facial palsy following the operation. For all the patients the mean follow-up period was 25.8 months (range 4–108 months). CONCLUSION: In conclusion, based on our findings and literature review, total surgical excision alone or with preoperative embolization is the main treatment modality for TBPs. However radiotherapy, observation protocol and subtotal resection must be considered in cases of preoperative functioning cranial nerves, large tumors and advanced age. Elsevier 2016-12-08 /pmc/articles/PMC9442861/ /pubmed/28011121 http://dx.doi.org/10.1016/j.bjorl.2016.11.001 Text en © 2016 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Article Düzlü, Mehmet Tutar, Hakan Karamert, Recep Karaloğlu, Furkan Şahin, Muammer Melih Göcek, Mehmet Uğur, Mehmet Birol Göksu, Nebil Temporal bone paragangliomas: 15 years experience() |
title | Temporal bone paragangliomas: 15 years experience() |
title_full | Temporal bone paragangliomas: 15 years experience() |
title_fullStr | Temporal bone paragangliomas: 15 years experience() |
title_full_unstemmed | Temporal bone paragangliomas: 15 years experience() |
title_short | Temporal bone paragangliomas: 15 years experience() |
title_sort | temporal bone paragangliomas: 15 years experience() |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442861/ https://www.ncbi.nlm.nih.gov/pubmed/28011121 http://dx.doi.org/10.1016/j.bjorl.2016.11.001 |
work_keys_str_mv | AT duzlumehmet temporalboneparagangliomas15yearsexperience AT tutarhakan temporalboneparagangliomas15yearsexperience AT karamertrecep temporalboneparagangliomas15yearsexperience AT karaloglufurkan temporalboneparagangliomas15yearsexperience AT sahinmuammermelih temporalboneparagangliomas15yearsexperience AT gocekmehmet temporalboneparagangliomas15yearsexperience AT ugurmehmetbirol temporalboneparagangliomas15yearsexperience AT goksunebil temporalboneparagangliomas15yearsexperience |